Coronary Stent Co-Inventor and Gene Therapy Pioneer, Dr. Richard Schatz, Joins GATC Health as Chairman of its Medical Advisory Board

IRVINE, Calif., Nov. 10, 2022 /PRNewswire/ — GATC Health (“GATC” or “the Company”), a science and technology company revolutionizing drug discovery and disease prediction using artificial intelligence (AI), today announced that Dr. Richard Schatz has joined its Medical Advisory Board as…